330 related articles for article (PubMed ID: 24258282)
1. Nanoparticulate assembly of mannuronic acid- and guluronic acid-rich alginate: oral insulin carrier and glucose binder.
Kadir A; Mokhtar MT; Wong TW
J Pharm Sci; 2013 Dec; 102(12):4353-63. PubMed ID: 24258282
[TBL] [Abstract][Full Text] [Related]
2. Oral calcium pectinate-insulin nanoparticles: influences of alginate, sodium chloride and Tween 80 on their blood glucose lowering performance.
Wong TW; Sumiran N
J Pharm Pharmacol; 2014 May; 66(5):646-57. PubMed ID: 24329400
[TBL] [Abstract][Full Text] [Related]
3. Alginate/chitosan nanoparticles are effective for oral insulin delivery.
Sarmento B; Ribeiro A; Veiga F; Sampaio P; Neufeld R; Ferreira D
Pharm Res; 2007 Dec; 24(12):2198-206. PubMed ID: 17577641
[TBL] [Abstract][Full Text] [Related]
4. Preparation and evaluation of alginate-chitosan microspheres for oral delivery of insulin.
Zhang Y; Wei W; Lv P; Wang L; Ma G
Eur J Pharm Biopharm; 2011 Jan; 77(1):11-9. PubMed ID: 20933083
[TBL] [Abstract][Full Text] [Related]
5. Preparation and evaluation of mucinated sodium alginate microparticles for oral delivery of insulin.
Builders PF; Kunle OO; Okpaku LC; Builders MI; Attama AA; Adikwu MU
Eur J Pharm Biopharm; 2008 Nov; 70(3):777-83. PubMed ID: 18644444
[TBL] [Abstract][Full Text] [Related]
6. Alginate coated chitosan core shell nanoparticles for oral delivery of enoxaparin: in vitro and in vivo assessment.
Bagre AP; Jain K; Jain NK
Int J Pharm; 2013 Nov; 456(1):31-40. PubMed ID: 23994363
[TBL] [Abstract][Full Text] [Related]
7. Design of oral intestinal-specific alginate-vitexin nanoparticulate system to modulate blood glucose level of diabetic rats.
Shaedi N; Naharudin I; Choo CY; Wong TW
Carbohydr Polym; 2021 Feb; 254():117312. PubMed ID: 33357875
[TBL] [Abstract][Full Text] [Related]
8. pH-sensitive chitosan/alginate core-shell nanoparticles for efficient and safe oral insulin delivery.
Mukhopadhyay P; Chakraborty S; Bhattacharya S; Mishra R; Kundu PP
Int J Biol Macromol; 2015 Jan; 72():640-8. PubMed ID: 25239194
[TBL] [Abstract][Full Text] [Related]
9. Nanoparticulate delivery system for insulin: design, characterization and in vitro/in vivo bioactivity.
Reis CP; Ribeiro AJ; Houng S; Veiga F; Neufeld RJ
Eur J Pharm Sci; 2007 Apr; 30(5):392-7. PubMed ID: 17280820
[TBL] [Abstract][Full Text] [Related]
10. Alginate microspheres prepared by internal gelation: development and effect on insulin stability.
Silva CM; Ribeiro AJ; Figueiredo IV; Gonçalves AR; Veiga F
Int J Pharm; 2006 Mar; 311(1-2):1-10. PubMed ID: 16442757
[TBL] [Abstract][Full Text] [Related]
11. Development of a novel drug delivery system: chitosan nanoparticles entrapped in alginate microparticles.
Garrait G; Beyssac E; Subirade M
J Microencapsul; 2014; 31(4):363-72. PubMed ID: 24697173
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of mucoadhesive hydrogel microparticles of whey protein and alginate for oral insulin delivery.
Déat-Lainé E; Hoffart V; Garrait G; Jarrige JF; Cardot JM; Subirade M; Beyssac E
Pharm Res; 2013 Mar; 30(3):721-34. PubMed ID: 23093377
[TBL] [Abstract][Full Text] [Related]
13. Probing insulin's secondary structure after entrapment into alginate/chitosan nanoparticles.
Sarmento B; Ferreira DC; Jorgensen L; van de Weert M
Eur J Pharm Biopharm; 2007 Jan; 65(1):10-7. PubMed ID: 17101268
[TBL] [Abstract][Full Text] [Related]
14. Controlling of systemic absorption of gliclazide through incorporation into alginate beads.
Al-Kassas RS; Al-Gohary OM; Al-Faadhel MM
Int J Pharm; 2007 Aug; 341(1-2):230-7. PubMed ID: 17507189
[TBL] [Abstract][Full Text] [Related]
15. Chitosan-Coated Alginate Nanoparticles Enhanced Absorption Profile of Insulin Via Oral Administration.
Jaafar MHM; Hamid KA
Curr Drug Deliv; 2019; 16(7):672-686. PubMed ID: 31250754
[TBL] [Abstract][Full Text] [Related]
16. Effect of mucoadhesive polymers on the in vitro performance of insulin-loaded silica nanoparticles: Interactions with mucin and biomembrane models.
Andreani T; Miziara L; Lorenzón EN; de Souza AL; Kiill CP; Fangueiro JF; Garcia ML; Gremião PD; Silva AM; Souto EB
Eur J Pharm Biopharm; 2015 Jun; 93():118-26. PubMed ID: 25843239
[TBL] [Abstract][Full Text] [Related]
17. Oral delivery of insulin from alginate/chitosan crosslinked by glutaraldehyde.
Tahtat D; Mahlous M; Benamer S; Khodja AN; Oussedik-Oumehdi H; Laraba-Djebari F
Int J Biol Macromol; 2013 Jul; 58():160-8. PubMed ID: 23567292
[TBL] [Abstract][Full Text] [Related]
18. Alginate microparticles as novel carrier for oral insulin delivery.
Reis CP; Ribeiro AJ; Neufeld RJ; Veiga F
Biotechnol Bioeng; 2007 Apr; 96(5):977-89. PubMed ID: 17001630
[TBL] [Abstract][Full Text] [Related]
19. Nanoemulsions coated with alginate/chitosan as oral insulin delivery systems: preparation, characterization, and hypoglycemic effect in rats.
Li X; Qi J; Xie Y; Zhang X; Hu S; Xu Y; Lu Y; Wu W
Int J Nanomedicine; 2013; 8():23-32. PubMed ID: 23293517
[TBL] [Abstract][Full Text] [Related]
20. Preparation, characterization and in vivo evaluation of pH sensitive, safe quercetin-succinylated chitosan-alginate core-shell-corona nanoparticle for diabetes treatment.
Mukhopadhyay P; Maity S; Mandal S; Chakraborti AS; Prajapati AK; Kundu PP
Carbohydr Polym; 2018 Feb; 182():42-51. PubMed ID: 29279124
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
